Link Cell Therapies Announces $60M Series A Financing

Core Insights - Link Cell Therapies has officially launched from stealth mode with a $60 million Series A financing round [1][2] Group 1: Financing Details - The Series A financing was led by Johnson & Johnson through its corporate venture capital organization, Johnson & Johnson Innovation - JJDC, Inc. [2] - Founding investors include Samsara BioCapital and Sheatree Capital, along with participation from Wing Venture Capital and other new strategic and financial investors [2]